13G Filing: Knoll Capital Management Files on Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Page 2 of 7 SEC Filing

Cusip
No.  
21833P103
13G Page
2 of 7 Pages

1.

NAME OF REPORTING PERSONS

Knoll Capital Management, LP

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)

(a)     ¨

(b)    x

3. SEC USE ONLY
4.

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5.

SOLE VOTING POWER

0

6.

SHARED VOTING POWER

 

2,563,925

7.

SOLE DISPOSITIVE POWER

0

8.

SHARED DISPOSITIVE POWER

2,563,925

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,563,925

10.

CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES

CERTAIN SHARES ¨

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.96%

12.

TYPE OF REPORTING PERSON

PN

Page 2 of 7

Follow Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)